Multiple Endocrine Neoplasia Type 2 — Trials

Multiple Endocrine Neoplasia Type 2 — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00514046	Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer	completed	Phase 1 / Phase 2	17	National Cancer Institute (NCI)NIH	1	Dec 22, 2020	clinicaltrials
NCT02831179	Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor	withdrawn	Phase 1	0	Vanderbilt-Ingram Cancer CenterOTHER	0	Sep 28, 2017	clinicaltrials

Data updated 22 days agoSource updated Dec 22, 2020source: clinicaltrials